On decreasing inequality in health care in a cost-effective way

BMC Health Services Research

Antti Malmivaara¹ 

[1] Centre for Health and Social Economics, National Institute for Health and Welfare, Mannerheimintie 166, 00270 Helsinki, Finland

关键词: Socioeconomic status;    Real effectiveness medicine;    Quality improvement;    Medical ethics;    Inequality;    Evidence based medicine;    Cost-effectiveness;    Benchmarking;   

Others  :  1134070
DOI  :  10.1186/1472-6963-14-79

 received in 2013-06-14, accepted in 2014-02-13,  发布年份 2014

【 摘 要 】

Background

Scientific evidence indicates that access to health care services shown effective is often poorer among the disadvantaged people than among the non-disadvantaged. Advancing cost-effectiveness and equality in obtaining services shown effective are often stated as the two main objectives for health care.

Discussion

The important question is how to decrease inequality in a most cost-effective way. Some evidence indicates that effectiveness and cost-effectiveness of interventions may be high among the disadvantaged patient groups. However, the relationship between decreasing inequality and cost-effectiveness is complex and depend e.g. on clinical and health care system factors.

Summary

To expand the knowledge base for advancing equality in a cost-effective way, scientific efforts on four levels are suggested: research into ways how practitioners can provide efficient services for the disadvantaged patients, widening of scope at all levels of evidence based medicine to account also for the disadvantaged, research on quality improvement and evidence implementation, as well as benchmarking research including documentation of services among the disadvantaged.

【 授权许可】

   
2014 Malmivaara; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Tugwell P, Petticrew M, Robinson V, Kristjansson E, Maxwell L, Cochrane Equity Field Editorial Team: Cochrane and Campbell collaborations and health equity. Lancet 2006, 367(9517):1128-1130.
• [2]Addo J, Bhalla A, Crichton S, Rudd AG, McKevitt C, Wolfe CD: Provision of acute stroke care and associated factors in a multiethnic population: prospective study with the South London Stroke Register. BMJ 2011, 342:d744.
• [3]Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S: Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 2008, 372(9650):1661-1669.
• [4]Forrest LF, Adams J, Wareham H, Rubin G, White M: Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med 2013, 10(2):e1001376.
• [5]Artuso S, Cargo M, Brown A, Daniel M: Factors influencing health care utilisation among Aboriginal cardiac patients in central Australia: a qualitative study. BMC Health Serv Res 2013, 13(83):1-13.
• [6]Grube MM, Koennecke HC, Walter G, Thummler J, Meisel A, Wellwood I, Heuschmann PU, on behalf of the Berlin Stroke Register: Association between socioeconomic status and functional impairment 3 months after ischemic stroke: the berlin stroke register. Stroke 2012, 43(12):3325-3330.
• [7]Gilman SE, Fitzmaurice GM, Bruce ML, Ten Have T, Glymour MM, Carliner H, Alexopoulos GS, Mulsant BH, Reynolds , Charles F III, Cohen A: Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideation. Epidemiology 2013, 24(1):14-22.
• [8]Mayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA: Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis. BMJ 2011, 343:d5094.
• [9]Carrera C, Azrack A, Begkoyian G, Pfaffmann J, Ribaira E, O’Connell T, Doughty P, Aung KM, Prieto L, Rasanathan K, Sharkey A, Chopra M, Knippenberg R, UNICEF Equity in Child Survival, Health and Nutrition Analysis Team: The comparative cost-effectiveness of an equity-focused approach to child survival, health, and nutrition: a modelling approach. Lancet 2012, 380(9850):1341-1351.
• [10]NSW Centre for Overweight and Obesity: A literature review of the evidence for interventions to address overweight and obesity in adults and older Australians. 2005, 1-56.
• [11]Wagstaff A, van Doorslaer E: Overall versus socioeconomic health inequality: a measurement framework and two empirical illustrations. Health Econ 2004, 13(3):297-301.
• [12]Whitehead M, Evandrou M, Haglund B, Diderichsen F: As the health divide widens in Sweden and Britain, what’s happening to access to care? BMJ 1997, 315(7114):1006-1009.
• [13]Hernandex-Quevedo C, Papanicolas I: Conceptualizing and Comparing Equity across Nations. In Health System Performance Comparison. An Agenda for Policy, Information and Research. 1st edition. Edited by Anonymous Maidenhead. England: Open University Press; 2013.
• [14]Wagstaff A: Inequality aversion, health inequalities and health achievement. J Health Econ 2002, 21(4):627-641.
• [15]Malmivaara A: Real-effectiveness medicine-pursuing the best effectiveness in the ordinary care of patients. Ann Med 2013, 45(2):103-106.
• [16]Laba TL, Bleasel J, Brien JA, Cass A, Howard K, Peiris D, Redfern J, Salam A, Usherwood T, Jan S: Strategies to improve adherence to medications for cardiovascular diseases in socioeconomically disadvantaged populations: A systematic review. Int J Cardiol 2013, 167:2430-2440.
• [17]Frank JR, Jabbour M, Fréchette D, Marks M, Valk N, Bourgeois G (Eds): Report of the CanMEDS Phase IV. Working Groups. Ottawa: The Royal College of Physicians and Surgeons of Canada; 2005.
• [18]Bellera C, Praud D, Petit-Moneger A, McKelvie-Sebileau P, Soubeyran P, Mathoulin-Pelissier S: Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin’s lymphoma: a systematic review. Cancer Treat Rev 2013, 39:812-817.
• [19]Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869.
• [20]Welch V, Brand K, Kristjansson E, Smylie J, Wells G, Tugwell P: Systematic reviews need to consider applicability to disadvantaged populations: inter-rater agreement for a health equity plausibility algorithm. BMC Med Res Methodol 2012, 12:187-195. BioMed Central Full Text
• [21]Tugwell P, Maxwell L, Welch V, Kristjansson E, Petticrew M, Wells G, Buchbinder R, Suarez-Almazor ME, Nowlan M, Ueffing E, Khan M, Shea B, Tsikata S: Is health equity considered in systematic reviews of the Cochrane musculoskeletal group? Arthritis Rheum-Arthritis Care Res 2008, 59(11):1603-1610.
• [22]Welch V, Petticrew M, Tugwell P, Moher D, O’Neill J, Waters E, White H, PRISMA-Equity Bellagio Grp: PRISMA-equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLos Med 2012, 9(10):e1001333.
• [23]Berkowitz SA, Aragon K, Hines J, Seligman H, Lee S, Sarkar U: Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? A systematic review. Health Serv Res 2013, 48:1299-1310.
• [24]Collaboration AGREE: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003, 12(1):18-23.
• [25]Häkkinen U, Malmivaara A: The PERFECT project: measuring performance of health care episodes [Guest editors]. Ann Med 2011., 43(Suppl1)
• [26]Tugwell P, de Savigny D, Hawker G, Robinson V: Applying clinical epidemiological methods to health equity: the equity effectiveness loop. BMJ 2006, 332(7537):358-361.
• [27]McCallum AK, Manderbacka K, Arffman M, Leyland AH, Keskimaki I: Socioeconomic differences in mortality amenable to health care among Finnish adults 1992-2003: 12 year follow up using individual level linked population register data. BMC Health Serv Res 2013, 13(1):3. BioMed Central Full Text
• [28]Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, Schneider EC, Wright BJ, Zaslavsky AM, Finkelstein AN, Carlson M, Edlund T, Gallia C, Smith J, Oregon Health Study Group: The Oregon experiment–effects of Medicaid on clinical outcomes. N Engl J Med 2013, 368(18):1713-1722.